EP4023210A1 — Orodispersible powder composition
Assigned to Biopharma Synergies SL · Expires 2022-07-06 · 4y expired
What this patent protects
The present invention relates to an orodispersible powder composition comprising an active pharmaceutical ingredient and a ternary synergistic combination of sodium citrate, citric acid and sucralose. It also relates to a stick pack and a tablet comprising such orodispersible pow…
USPTO Abstract
The present invention relates to an orodispersible powder composition comprising an active pharmaceutical ingredient and a ternary synergistic combination of sodium citrate, citric acid and sucralose. It also relates to a stick pack and a tablet comprising such orodispersible powder composition, and their use as a medicament.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.